Teva Pharmaceutical Industries Limited American Depositary Shares(TEVA)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $14.99 – $37.34
- YTD
- +12.76%
- IV Rank (30D)
- 17.37
- Straddle Price
- $3.09
- P/C Vol Ratio
- 0.13
- Market Cap
- $36.9B
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.69% |
| Beta vs SPY | 1.00 |
| Cost of Equity (CAPM) | 10.19% (VRP-adj) |
| WACC | 8.59% |
| Volatility Risk Premium | +17.9pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +21.1% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.10 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $1.2B |
| Return on Equity (TTM) | 19.0% |
| Book / Price | 21.5% |
| Gross Margin (TTM) | 51.8% |
| FCF Margin (TTM) | 6.8% |
| Debt / Equity | 1.89 |
| Quality Score | 3/6 — normal (10y DCF) |
| Market-Implied Growth | +17.7% (reverse-DCF on current price) |
| SMA 50 | $33.25 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $32.43 |
| Bollinger Width / SMA20 | 53.6% (drives anchor stability) |
| Net Debt | $11.4B |
| Market Cap | $37B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $40.56 | 30% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $40.22 | 14% | median 30.5× · 7 peers |
| Peer EV/EBITDA | $88.79 | 14% | median 21.1× · 7 peers |
| Peer P/B | $47.58 | 3% | median 7.0× · 8 peers |
| Peer P/S | $124.27 | 9% | median 7.6× · 8 peers |
| Market Anchor (SMA50) | $33.25 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | $34.17 | 30% | 20 strikes · skew -1.01 |
- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834)
- Exchange
- XNYS
- Market Cap
- $36.9B
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distribut…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +2.74% | 6 |
| Feb | -3.65% | 6 |
| Mar | -2.99% | 6 |
| Apr | -0.19% | 6 |
| May | +3.51% | 6 |
| Jun | -4.58% | 6 |
| Jul | +5.73% | 6 |
| Aug | +3.58% | 5 |
| Sep | -1.71% | 5 |
| Oct | -1.06% | 5 |
| Nov | +3.44% | 5 |
| Dec | +10.52% | 5 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-07-31 | Pre-Market | 9.88% | 4.82% | 0.49x | Within |
| 2024-11-06 | Pre-Market | 7.88% | 6.62% | 0.84x | Within |
| 2025-01-29 | Pre-Market | 7.48% | 13.89% | 1.86x | Exceeded |
| 2025-05-07 | Pre-Market | 9.18% | 7.97% | 0.87x | Within |
| 2025-07-30 | Pre-Market | 8.24% | 1.76% | 0.21x | Within |
| 2025-11-05 | Pre-Market | 6.99% | 20.09% | 2.87x | Exceeded |
| 2026-01-28 | Pre-Market | 6.92% | 2.43% | 0.35x | Within |
| 2026-04-29 | Pre-Market | 12.18% | 11.95% | 0.98x | Within |
- IV Rank (30D)
- 17.37
- IV Rank (7D)
- 68.0
- Avg IV
- 52.0%
- Straddle (30D)
- $3.09
- Straddle (7D)
- $1.85
- P/C Volume
- 0.13
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
- Beta (1Y vs SPY)
- 0.78
- Correlation (SPY)
- 24.2%
- R²
- 0.06
- Ann. Volatility
- 41.1%
- SPY Volatility
- 12.7%
Low volatility - stock moves less than market
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $219.99M | 33.29% | 2026-03-31 |
| 2 | Walleye Trading LLC | $77.32M | 11.70% | 2026-03-31 |
| 3 | CITADEL ADVISORS LLC Custodian | $58.20M | 8.81% | 2026-03-31 |
| 4 | Nantahala Capital Management, LLC | $45.18M | 6.84% | 2026-03-31 |
| 5 | JANE STREET GROUP, LLC Custodian | $34.89M | 5.28% | 2026-03-31 |
| 6 | Caption Management, LLC | $32.82M | 4.97% | 2026-03-31 |
| 7 | PICTON MAHONEY ASSET MANAGEMENT | $30.12M | 4.56% | 2026-03-31 |
| 8 | UBS Group AG Custodian | $25.41M | 3.84% | 2026-03-31 |
| 9 | SIMPLEX TRADING, LLC Custodian | $19.37M | 2.93% | 2026-03-31 |
| 10 | MILLENNIUM MANAGEMENT LLC Custodian | $18.20M | 2.75% | 2026-03-31 |
| 11 | NOMURA HOLDINGS INC | $16.72M | 2.53% | 2026-03-31 |
| 12 | GROUP ONE TRADING LLC Custodian | $16.52M | 2.50% | 2026-03-31 |
| 13 | Squarepoint Ops LLC | $16.02M | 2.42% | 2026-03-31 |
| 14 | IMC-Chicago, LLC Custodian | $13.73M | 2.08% | 2026-03-31 |
| 15 | CAPITAL FUND MANAGEMENT S.A. | $6.48M | 0.98% | 2026-03-31 |
| 16 | HIGHLAND PEAK CAPITAL, LLC | $6.02M | 0.91% | 2026-03-31 |
| 17 | Walleye Capital LLC | $4.47M | 0.68% | 2026-03-31 |
| 18 | WOLVERINE TRADING, LLC Custodian | $4.15M | 0.63% | 2025-09-30 |
| 19 | TUDOR INVESTMENT CORP ET AL | $3.82M | 0.58% | 2026-03-31 |
| 20 | Centiva Capital, LP | $3.77M | 0.57% | 2026-03-31 |
| 21 | Point72 Asset Management, L.P. | $2.36M | 0.36% | 2026-03-31 |
| 22 | JPMORGAN CHASE & CO Custodian | $1.55M | 0.23% | 2026-03-31 |
| 23 | Altshuler Shaham Ltd | $1.26M | 0.19% | 2026-03-31 |
| 24 | BOOTHBAY FUND MANAGEMENT, LLC | $1.26M | 0.19% | 2026-03-31 |
| 25 | PEAK6 LLC | $608.42K | 0.09% | 2026-03-31 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $155.18M | 40.41% | 2026-03-31 |
| 2 | Walleye Trading LLC | $63.52M | 16.54% | 2026-03-31 |
| 3 | CITADEL ADVISORS LLC Custodian | $38.42M | 10.00% | 2026-03-31 |
| 4 | JANE STREET GROUP, LLC Custodian | $22.25M | 5.79% | 2026-03-31 |
| 5 | Caption Management, LLC | $20.32M | 5.29% | 2026-03-31 |
| 6 | Squarepoint Ops LLC | $15.13M | 3.94% | 2026-03-31 |
| 7 | Point72 Asset Management, L.P. | $11.55M | 3.01% | 2026-03-31 |
| 8 | SIMPLEX TRADING, LLC Custodian | $9.97M | 2.60% | 2026-03-31 |
| 9 | IMC-Chicago, LLC Custodian | $8.23M | 2.14% | 2026-03-31 |
| 10 | TUDOR INVESTMENT CORP ET AL | $7.03M | 1.83% | 2026-03-31 |
| 11 | NATIONAL BANK OF CANADA /FI/ Custodian | $6.02M | 1.57% | 2026-03-31 |
| 12 | GROUP ONE TRADING LLC Custodian | $5.30M | 1.38% | 2026-03-31 |
| 13 | WOLVERINE TRADING, LLC Custodian | $4.17M | 1.09% | 2025-09-30 |
| 14 | CAPITAL FUND MANAGEMENT S.A. | $3.43M | 0.89% | 2026-03-31 |
| 15 | PEAK6 LLC | $3.01M | 0.78% | 2026-03-31 |
| 16 | UBS Group AG Custodian | $2.71M | 0.71% | 2026-03-31 |
| 17 | Crawford Fund Management, LLC | $2.20M | 0.57% | 2026-03-31 |
| 18 | Walleye Capital LLC | $1.80M | 0.47% | 2026-03-31 |
| 19 | Verition Fund Management LLC | $1.54M | 0.40% | 2026-03-31 |
| 20 | JPMORGAN CHASE & CO Custodian | $1.42M | 0.37% | 2026-03-31 |
| 21 | MILLENNIUM MANAGEMENT LLC Custodian | $475.90K | 0.12% | 2026-03-31 |
| 22 | SUMMIT SECURITIES GROUP LLC | $301.20K | 0.08% | 2026-03-31 |
| 23 | Capital Markets Trading UK LLP | $22.79K | <0.01% | 2026-03-31 |
| 24 | CMT Capital Markets Trading GmbH | $6.87K | <0.01% | 2026-03-31 |
| 25 | WOLVERINE ASSET MANAGEMENT LLC | $3.01K | <0.01% | 2026-03-31 |
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-06-22 | Matthew Shields | EVP, Global Operations | Sell (S) | −9,989 | $32.19 | -$321.5K | EDGAR |
| 2026-06-16 | Eliyahu Sharon Kalif | EVP, Chief Financial Officer | Sell (S) | −106,563 | $34.10 | -$3.63M | EDGAR |
| 2026-06-08 | Tal Zvi Zaks | Director | Exer (M) | +14,492 | — | EDGAR | |
| 2026-06-08 | Richard D Francis | President and CEO | Mixed | +6,890 | $34.35 | -$211.4K | EDGAR |
| 2026-06-08 | Perry Nisen | Director | Exer (M) | +14,492 | — | EDGAR | |
| 2026-06-08 | Chen Lichtenstein | Director | Exer (M) | +14,492 | — | EDGAR | |
| 2026-06-08 | Ronit Satchi-Fainaro | Director | Exer (M) | +14,492 | — | EDGAR | |
| 2026-06-08 | Amir Elstein | Director | Exer (M) | +14,492 | — | EDGAR | |
| 2026-06-08 | Rosemary A Crane | Director | Exer (M) | +14,492 | — | EDGAR | |
| 2026-06-08 | ROBERTO MIGNONE | Director | Exer (M) | +14,492 | — | EDGAR | |
| 2026-06-08 | SOL J BARER | Director | Exer (M) | +21,739 | — | EDGAR | |
| 2026-06-08 | GERALD M LIEBERMAN | Director | Exer (M) | +14,492 | — | EDGAR | |
| 2026-06-04 | Matthew Shields | EVP, Global Operations | Mixed | — | $32.87 | -$532.3K | EDGAR |
| 2026-06-01 | SOL J BARER | Director | Grant (A) | +10,863 RSU | — | EDGAR | |
| 2026-06-01 | Amir Elstein | Director | Grant (A) | +7,242 RSU | — | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Amir Elstein | Director | 2,118,455 | $73.90M | $0 | 19 | 2026-06-08 |
| 2 | Kare Schultz | President and CEO | 1,542,471 | $53.81M | $0 | 15 | 2022-11-02 |
| 3 | Richard D Francis | President and CEO | 1,177,529 | $41.08M | -$34.82M | 15 | 2026-06-08 |
| 4 | ROBERTO MIGNONE | Director | 487,407 | $17.00M | -$9.16M | 23 | 2026-06-08 |
| 5 | SOL J BARER | Director | 448,011 | $15.63M | $2.00M | 22 | 2026-06-08 |
| 6 | Dan S Suesskind | Director | 318,836 | $11.12M | $0 | 1 | 2018-01-23 |
| 7 | Sven Dethlefs | EVP, North America Commercial | 165,381 | $5.77M | -$2.11M | 26 | 2023-03-08 |
| 8 | Eric Drape | Executive VP Global Operations | 145,915 | $5.09M | -$4.46M | 23 | 2024-03-07 |
| 9 | GERALD M LIEBERMAN | Director | 130,149 | $4.54M | $0 | 19 | 2026-06-08 |
| 10 | Rosemary A Crane | Director | 127,739 | $4.46M | -$34.0K | 19 | 2026-06-08 |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
| P/E Ratio | 29.1 |
| P/B Ratio | 4.4 |
| P/S Ratio | 2.1 |
| EV/EBITDA | 9.8 |
| TTM Revenue | $17.3B |
| TTM Net Income | $1.4B |
| TTM EPS | $1.2 |
| ROE | 19.0% |
| Debt/Equity | 2.02 |